Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other financing activities (2018 - 2020)

Historic Other financing activities for Standard Biotools (LAB) over the last 3 years, with Q2 2020 value amounting to $18000.0.

  • Standard Biotools' Other financing activities rose 2000.0% to $18000.0 in Q2 2020 from the same period last year, while for Jun 2021 it was $375000.0, marking a year-over-year decrease of 2544.73%. This contributed to the annual value of $2.9 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Standard Biotools reported Other financing activities of $18000.0 as of Q2 2020, which was up 2000.0% from $357000.0 recorded in Q1 2020.
  • In the past 5 years, Standard Biotools' Other financing activities registered a high of $2.6 million during Q2 2018, and its lowest value of $15000.0 during Q2 2019.
  • Its 3-year average for Other financing activities is $420625.0, with a median of $98000.0 in 2018.
  • In the last 5 years, Standard Biotools' Other financing activities plummeted by 9941.31% in 2019 and then surged by 2000.0% in 2020.
  • Over the past 3 years, Standard Biotools' Other financing activities (Quarter) stood at $83000.0 in 2018, then surged by 36.14% to $113000.0 in 2019, then tumbled by 84.07% to $18000.0 in 2020.
  • Its Other financing activities stands at $18000.0 for Q2 2020, versus $357000.0 for Q1 2020 and $113000.0 for Q3 2019.